The development of Jack Jumper ant venom immunotherapy: our 25 years' experience.

Abstract

Jack Jumper ant venom allergy is a uniquely Australian medical issue. The stinging ant is a leading cause of insect venom allergy in south-eastern Australia. An effective venom immunotherapy-based treatment was successfully developed by the Tasmanian Jack Jumper Allergy Research group. This paper provides a synopsis of our 25 years' research journey in developing this evidence-based treatment modality.

• Authors: Troy Wanandy, Thanh-Thao A Le, Wun Y Lau, Michael D Wiese, Robert J Heddle, Simon G A Brown
• Journal: Internal medicine journal (Intern Med J) Vol. 53 Issue 9 Pg. 1716-1721 (09 2023) ISSN: 1445-5994 [Electronic] Australia
• PMID: 37743244 (Publication Type: Journal Article)
• Copyright: © 2023 Royal Australasian College of Physicians.

Topics

• Humans
• Animals
• Ants
• Australia
• Desensitization, Immunologic
• Hypersensitivity (therapy)
• Pain